Organization
Afimmune
3 clinical trials
Clinical trial
An Open-label Mechanistic Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Orally Administered Epeleuton in Patients With Sickle Cell DiseaseStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Randomised, Double-Blind, Placebo-Controlled, Dose Finding Phase IIb Study to Assess the Efficacy and Safety of Orally Administered Epeleuton in Patients With Hypertriglyceridemia and Type 2 DiabetesStatus: Terminated, Estimated PCD: 2022-05-03
Clinical trial
A Randomised, Double-Blind, Placebo-Controlled, Exploratory Phase IIa Study To Assess The Safety And Efficacy Of Orally Administered Epeleuton In NAFLD Patients.Status: Completed, Estimated PCD: 2019-01-02